Exploring how health plans and hemophilia treatment centers can better work together to deliver high-quality care and manage costs associated with hemophilia.
Robert Kaminsky, MBA
Advertisement
Articles by Robert Kaminsky, MBA
In September 2009, the Pharmacy & Therapeutics Society gathered a study group of 12 managed care medical and pharmacy directors. The objective was to examine the impact that biomarker-based assays could have on the approaches payers and providers use to manage cancer.
Advertisement
Latest Updated Articles
- Staging Colon Cancer: New Directions and Managed Care Implications
Published: April 6th 2010 | Updated:
- Hemophilia and Managed Care: Partnering to Achieve Cost-Effective Care
Published: September 30th 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Ban Synthetic 7-OH: Natural Leaf Kratom Presents No Major Health Risk
2
Is Berberine Nature’s GLP-1?
3
Glucodensity Analysis Enhances CGM Accuracy for Detecting Cystic Fibrosis–Related Diabetes
4
Influenza Burden Among Agricultural Households Highlights Need for Broader Vaccination Programs
5
